Healthtech Startups

OFFOR Health provides mobile healthcare services to underserved populations in the United States, operating SmileMD for in-office anesthesia and sedation during pediatric dental procedures and IH Care+ for integrated health access. The company brings care directly to patients and dental offices to avoid hospital visits.

2 investors

Ognomy Sleep is a virtual platform providing end-to-end sleep apnea diagnosis and treatment through licensed sleep medicine specialists. The service delivers convenient, affordable care to patients across all 50 US states.

2 investors

Oivi provides a fully automated retinal screening solution that lets primary care staff perform diabetic eye screening in minutes without specialist training, delivering results within the clinical workflow. It targets primary care clinics in the US to close the diabetic retinopathy screening gap and detect eye diseases such as cataract and glaucoma.

2 investors

Ojer Pharma develops pharmaceutical and cosmetic products for treating skin conditions and infections in human and veterinary markets. The company offers prescription medications, over-the-counter treatments, and dermatological cosmetics addressing conditions ranging from bacterial skin infections to actinic keratosis and herpes simplex.

2 investors

OK2StandUP develops smart activity monitoring systems with AI-based alerts for healthcare organizations to prevent falls and support caregiver awareness in patient care settings. The solution serves hospitals, rehabilitation facilities, memory care facilities, and other care environments for older adults.

2 investors

oladoc is a digital healthcare platform in Pakistan that lets patients find and book in-person appointments or online video consultations with PMDC-verified doctors across 100+ specialties. It offers patient reviews, consultation fees, and wait times, and can also be used to book specialty treatments, hospitals, or lab tests.

2 investors

Olfera develops biopharmaceutical treatments for neurological conditions that use the olfactory system as a non-invasive pathway to the brain, bypassing the blood-brain barrier. Its platform is used to discover, optimize, and deliver drugs, converting existing FDA-approved and candidate neurological drugs into easier-to-administer therapies.

2 investors

OLI Technologies develops technology for decentralizing kidney care, working on chemistry, mechanical, and software engineering to support treatment outside centralized clinical settings. The company is developing a medical device, having completed its first animal study.

2 investors

Olio provides care coordination technology for post-acute and behavioral health organizations, automatically connecting care teams across SNFs, behavioral health providers, payers, health systems, home health, and hospice to improve outcomes and reduce costs.

2 investors

Olly is a wellness and nutrition brand that develops and sells vitamins, probiotics, supplements, and personal care products targeting consumers focused on health outcomes including digestive health, stress management, sleep, and women's health.

2 investors

Hexoskin manufactures smart clothing with built-in textile sensors that monitor physiological data such as heart rate and sleep patterns; the system serves individuals tracking their health and fitness through wearable garments paired with mobile apps and cloud-based dashboards.

2 investors

OMEICOS is a biotech company developing small-molecule therapeutics based on synthetic analogues of omega-3 fatty acid derived epoxyeicosanoids (17,18-EEQ) for cardiovascular, inflammatory, and rare mitochondrial diseases. Its lead candidate OMT-28 is in Phase 2 clinical trials for conditions including atrial fibrillation and primary mitochondrial disease; the company was spun out of the Max Delbrück Center for Molecular Medicine in Berlin.

2 investors

Omeros is a publicly traded biotech company developing a diverse pipeline of first-in-class small-molecule and antibody therapeutics targeting unmet medical needs across multiple therapeutic areas and indications. The company pursues orphan, large-market, and novel therapeutic programs through vertically integrated drug development.

2 investors

Vedaly provides AI, data analytics, and decision support tools for biopharma companies to integrate insights into scientific and strategic planning. The platform helps pharmaceutical and biotech teams move faster and make data-driven decisions across drug development and research.

2 investors

Omni Saúde offers an employer-sponsored medication benefit in Brazil, providing employees a monthly credit via an app to buy prescription medicines at any pharmacy in the country. Purchases require a medical prescription and are paid through the app using PIX, with coverage determined by the plan the employer contracts.

2 investors

OmniLife Health builds FlowHawk, a clinical workflow automation platform that connects care teams and digitizes care coordination conversations happening outside the EHR. It is purpose-built for organ transplant and organ failure care at hospitals and health systems, with capabilities like organ intake, patient referral, and waitlist management.

2 investors

Omnix Medical is a biopharmaceutical company founded in 2015 that develops novel antibiotic agents to treat infections caused by drug-resistant bacteria. Its lead compound, OMN6, is a first-in-class antimicrobial in Phase II clinical trials targeting drug-resistant Acinetobacter baumannii infections.

2 investors

Ompractice provides live and on-demand yoga, meditation, tai chi, and other evidence-based movement and mindfulness classes through an online platform, serving individuals, health systems, libraries, and veteran organizations. The company focuses on making these wellness practices accessible to underserved populations and communities.

2 investors

On Belay provides tools, resources, and guidance to support primary care teams in transitioning to value-based care models and strengthening their practices across the United States. The company focuses on enabling relationships and coordination among care teams, patients, and communities to improve patient outcomes and practice sustainability.

2 investors

Oncimmune is a biomarker discovery and diagnostics company specializing in proteomics and bioinformatics technologies for autoimmunity, cancer research, and clinical drug development. The company serves pharmaceutical, biotech, and academic partners by developing diagnostic tools and biomarkers for various phases of clinical development.

2 investors

OncoC4 is a clinical-stage biopharmaceutical company developing immunotherapy treatments for cancer patients, based on research by its immunologist founders. It advances its pipeline through internal R&D and external partnerships, including a collaboration with BioNTech to develop and commercialize gotistobart.

2 investors

OncoInsight develops off-the-shelf natural killer (NK) cell therapy product candidates aimed at treating cancer patients. The company operates in the biotech and cell therapy space.

2 investors

Oncoliq develops early cancer detection technology that combines molecular biology and machine learning to offer a non-toxic, non-invasive, and low-cost diagnostic approach. The company operates in the cancer diagnostics field.

2 investors

Mereo BioPharma is a rare disease drug developer that funds and advances novel therapeutic candidates not progressed by their originating pharmaceutical or biotech companies, with lead programs in osteogenesis imperfecta and Alpha-1 Antitrypsin Deficiency-associated Lung Disease. It operates a capital-efficient model, retaining regional development rights while forming strategic partnerships, and collaborates with patient communities in the rare disease space.

2 investors